Oct 02, 2020
Oncology Closed Claims Study
The Doctors Company conducted a review of medical and surgical oncology claims that closed between 2012 and 2018. This study was based on claims and lawsuits filed against the more than 500 oncologists insured by The Doctors Company.
Search
Dec 05, 2025
As Wearables Improve, They Can Boost Patient Engagement and Lower Risks
More and more patients are tracking their biometrics through a wearable device. Practitioners who embrace and direct this interest can reap rewards in patient engagement and safety.
From
The Doctor’s Advocate
Effective Patient-Assisted Telehealth Assessments
Physicians who practice telemedicine must consider the components needed to complete an effective remote assessment and plan ahead based on their specialty area and the patient’s presenting complaint.
Professional Education
Module 6: Controlled Substance Utilization Review and Evaluation System (CURES) (Innovations and Smart Approaches in Safe Prescribing)
This program reviews the CURES electronic database for Schedule II, III, IV, V controlled substance prescriptions dispensed in California, including time requirements involved when dispensing information needs to be reported (a controlled substance is released to the patient or patient's representative). This module will examine how non-DEA licensed physicians and surgeon practitioners can access CURES data. This module consists of four audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
Mar 04, 2024
Patient Safety Impact Story: Documentation Can Prevent Litigation
Our experts partnered with a general surgery practice to dramatically improve its after-hours call documentation rate.
From
The Doctor’s Advocate
Expert Insights and Resources for Changing Healthcare
The Insurance Marketing and Communications Association (IMCA) recognized The Doctors Company for its exceptional efforts to educate and support healthcare professionals as they navigate the rapidly changing healthcare industry, especially as they adapt to evolving technologies.
Jan 30, 2025
Off-Label Use: Patient Safety Implications
Once authorized, a drug product may be prescribed by a licensed healthcare practitioner for any use deemed appropriate based on the practitioner’s professional opinion. The governing standard is what other similarly trained practitioners would do—not what the manufacturer of the medication or product recommends.
June 25, 2025, Business Insurance
Doctors Aren’t Talking Up Their Career: Survey
According to a recent study conducted by The Doctors Company, only 12 percent of doctors are likely to recommend that people join their profession.
February 12, 2023, Medical Device & Technology
Urgency Needed for Medical Grade Wearables
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, discusses the importance of understanding how technology like wearables impacts medical liability.
February 28, 2023, Medtech Insight
So the Public Health Emergency Is Over. Now What?
David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, provides insight about what the official end of the COVID-19 emergency means for average Americans.
